|
|
CCTRP Proposal Evaluation Information
I. Research Type/Stage
| 1. At what stage is the research? |
|
• Very early - hypothesis testing |
|
• Early - preliminary data |
|
• Mid - some pre-clinical testing |
|
• Late - prototype development |
|
• Very late - prototype testing |
|
• Not clear |
| 2. Is the proposed research translational? |
|
• Yes |
|
• No |
|
• Not clear |
II. Research Plan/Science
| 1. Is the science sound - based on good principles? |
|
• Yes |
|
• No |
|
• Questionable |
| 2. Is the research plan feasible? |
|
• Yes |
|
• No |
|
• Questionable |
| 3. Is the research plan appropriate, clearly presented with good models and statistics? |
|
• Yes |
|
• No |
|
• Questionable |
III. Clinical Impact
| 1. If successfully completed, would the research outcome? |
|
• Address a significant unmet clinical need |
|
• Address an under-met clinical need |
|
• Better address a need that is currently met |
|
• Does not really address an existing clinical need |
| 2. If a product based on this research becomes clinical, would it likely be characterized as |
|
• Revolutionary |
|
• Evolutionary |
|
• Me too |
IV. Collaboration
| 1. Does the application include collaboration with a clinical investigator who interacts with patients? |
|
• Yes |
|
• No |
| 2. Is the collaborating clinical investigator's involvement in the project substantive? |
|
• Yes |
|
• No |
|
• Unclear |
| 3. Does the collaborating clinical investigator possess the requisite experience and skills to contribute effectively to the proposed project? |
|
• Yes |
|
• No |
|
• Unclear |
V. Intellectual Property
| 1. Regarding the intellectual property associated with this proposal |
|
• Patents already exist |
|
• Patent applications have been filed (Provisional or Full) |
|
• Invention disclosures have been submitted |
|
• No IP activity yet |
|
• Status unclear |
| 2. If no IP activity yet, the IP potential is assessed as |
|
• Very likely patentable |
|
• Probably patentable |
|
• Probably not patentable |
|
• Very likely not patentable |
|
• Unclear |
| 3. If not patentable (e.g., software), is other proprietary protection likely? |
|
• Yes |
|
• No |
|
• Unclear |
VI. Commercialization Potential
| 1. Does the proposed research envision a commercial product? |
|
• Yes |
|
• No |
|
• Unclear |
| 2. What is the stage of the commercialization activity? |
|
• No activity, consideration, or strategy |
|
• Some strategic consideration |
|
• Clear plan developed, but no activity yet |
|
• Commercialization discussions ongoing with potential partners |
|
• Already licensed or optioned |
| 3. What is the earliest likely timeframe that a product resulting from this research could make it to market? |
|
• < 3 years |
|
• 3-5 years |
|
• 5-7 years |
|
• > 7 years |
|
• Unknown |
| 4. Do applicants have a clear, workable plan for follow-on funding after the Coulter funding ends? |
|
• Yes |
|
• No |
|
• Unclear |
VII. Intangibles
| This refers to assets of the enterprise that do not physically exist yet are considered to have value (i.e. ownership of a franchise, patent, goodwill). |
|
|
